Latest Serotonin-norepinephrine-dopamine reuptake inhibitor Stories
According to a new study, SSRIs can alter the brain’s architecture within hours, even though most patients don’t notice the effects until weeks of use.
Recent New York Times article generates fury of protest from clinicians NEW YORK, Sept.
Levels of a tiny molecule known as miR-1202 are lower in the brains of people suffering from depression, suggesting that it could serve as a marker for depression and help detect which patients are most likely to respond to antidepressant treatment.
Neurovance, Inc. today announced complete results from its phase 2a pilot study of EB-1020 SR, a non-stimulant, in adult male patients with all subtypes of ADHD (attention deficit hyperactivity disorder).
The street drug ketamine is now being looked at for its therapeutic value as a new study from UK researchers at Oxford University has found that relatively small doses of the drug are effective in treating depression.
Pediatric primary care practitioners (PCPs) are reluctant to prescribe antidepressant medications to adolescent patients—even those with severe depression.
Magnetic resonance imaging (MRI) provides a noninvasive way to measure iron levels in the brains of people with attention deficit hyperactivity disorder (ADHD)